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INVITED EDITORIAL
Multilocus FISH Analysis
Roberta A. Pagon
Division of Medical Genetics, Children’s Hospital and Medical Center, Seattle
In this issue of the Journal, Ligon et al. (1997) have lar-diagnostic laboratory testing. Through the clini-
demonstrated the technical feasibility of a multilocus cian’s use of the medical history, family history, and
FISH (MultiFISH) analysis, in which simultaneous use physical examination, the patient effectively undergoes
of different probes permits detection of several different a ‘‘genomewide scan’’ for a possible heritable disorder,
microdeletion syndromes. They propose that this meth- following which the clinician uses laboratory testing to
odology could be used as a screening tool for patients support or refute his or her diagnostic impressions.
who present with unexplained developmental delay and/ When disorders have overlapping phenotypes that may
or mental retardation. They base their recommendation not be readily distinguishable clinically, simultaneous
on cost-effective use of laboratory resources. The au- use of diagnostic tests is appropriate. For example, cy-
thors point out that such a screening tool would be togenetic fragile X testing was offered along with rou-
useful when a clinical diagnosis is difﬁcult to establish tine cytogenetic testing for years prior to discovery of
either because of an atypical phenotype or lack of clini- the FMR1 gene. More recently, fragile X DNA testing
cian skill. The multiFISH panel that was chosen by these has been combined with routine cytogenetics for
authors represents those disorders for which they have screening younger boys and females of all ages who
determined that good-quality FISH probes are available: have developmental delay and/or mental retardation.
Prader-Willi, Angelman, Williams, DiGeorge/velocardi- Currently, some laboratories are offering panels of mo-
ofacial and Smith-Magenis syndromes. lecular genetic tests for neurological disorders, such
There can be no doubt that FISH has greatly facili- as spinocerebellar ataxia type I, spinocerebellar ataxia
tated the diagnosis of these microdeletion syndromes— type III, Huntington disease, and DRPLA, in which the
especially in young patients, in whom all necessary diag- phenotypes are similar.
nostic ﬁndings may not yet have emerged, and in atypi- In contrast to these situations, it is more difﬁcult to
cal patients. For example, DiGeorge/velocardiofacial argue for the use of a panel of tests for disorders that
syndrome has a notoriously broad phenotype, which do not have signiﬁcantly overlapping features and that
has become even broader since the advent of molecular would not be considered in the differential diagnosis of
testing, and correct diagnosis of it on clinical grounds the same patient by a skilled clinician. In my experience,
alone can elude even the most experienced clinical genet- it would be a most unusual patient in whom a medical
icist/dysmorphologist. Ligon et al. have essentially asked geneticist would sequentially order testing on the ﬁve
us to revisit the role of the clinician versus molecular disorders proposed in the panel presented by Ligon et
testing in another instance—that is, when clinicians lack al. Thus, simultaneous use of these ﬁve FISH tests does
the skill to make or suspect diagnoses on clinical not appear to address a recognized clinical need.
grounds alone. Ligon et al. have suggested that lack of A signiﬁcant concern about genetic testing of any sort
clinician skill is a reason to create a panel of tests for derives from the common misperception that a normal
disparate disorders. In contrast, it is the opinion of result is an indication that ‘‘there is no genetic problem.’’
many—as it has been, even from the earliest days of For example, clinical geneticists hear this refrain repeat-
molecular-genetic testing—that the clinician plays a cen- edly from patients, families, and physicians who believe
tral role in the appropriate use of highly focused molecu- that a normal cytogenetic study has ruled out a genetic
basis for their concerns. Recent studies have shown that
clinicians who have a poor understanding of the nature
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disorder,’’ by families and nongeneticist practitioners multiFISH panels combined with direct DNA analysis,
for screening patients for disorders with overlappingalike. Rather, such studies should be offered in the con-
phenotypic features.text of a complete genetic evaluation in which all infor-
mation available is assessed by an experienced clinician
who focuses laboratory testing to support his or her References
clinical acumen.
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techniques (e.g., FISH) and direct DNA analysis. The Ligon AH, Beaudet AL, Shaffer LG (1997) Simultaneous,
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clinical geneticists to think about studying prospectively the diagnostic evaluation of developmental delay and mental
retardation. Am J Hum Genet 61:51–59 (in this issue)the cost-effectiveness and diagnostic efﬁciency of
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